CytomX GAAP EPS of $0.00 beats by $0.06, revenue of $18.7M beats by $0.42M
Source: SeekingAlpha
2025-08-07 16:18:23 ET
More on CytomX
- CytomX Therapeutics: Doubling Overnight On Phase 1 Data... Still Bullish?
- CytomX upgraded at H.C. Wainwright on trial data for cancer drug
Read the full article on Seeking Alpha
For further details see:
CytomX GAAP EPS of $0.00 beats by $0.06, revenue of $18.7M beats by $0.42M
CytomX Therapeutics Inc.
NASDAQ: CTMX
CTMX Trading
-1.58% G/L:
$4.675 Last:
1,737,279 Volume:
$4.90 Open:
CTMX Latest News
March 04, 2026 08:00:00 am
CytomX Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026
CTMX Stock Data
$945,449,504
141,817,426
0.97%
31
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
